Advances in the roles of glycyrrhizic acid in cancer therapy
- PMID: 37649893
- PMCID: PMC10463042
- DOI: 10.3389/fphar.2023.1265172
Advances in the roles of glycyrrhizic acid in cancer therapy
Erratum in
-
Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy.Front Pharmacol. 2023 Dec 14;14:1345663. doi: 10.3389/fphar.2023.1345663. eCollection 2023. Front Pharmacol. 2023. PMID: 38155900 Free PMC article.
Abstract
Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could alleviate cancer, they lead to different forms of side effects and have no particularly significant effect on prolonging the patients' life span. Glycyrrhizic acid (GL), a native Chinese herbal extract, has a wide range of pharmacological effects, such as anti-cancer, anti-inflammatory, antioxidant, and immune regulation. In this review, the anti-cancer effects and mechanisms of GL are summarized in various cancers. The inhibition of GL on chemotherapy-induced side effects, including hepatotoxicity, nephrotoxicity, genotoxicity, neurotoxicity and pulmonary toxicity, is highlighted. Therefore, GL may be a promising and ideal drug for cancer therapy.
Keywords: anti-cancer; cancer; glycyrrhizic acid; mechanisms; side effects.
Copyright © 2023 Zhang, Sheng, Xiao, Li, Huang, Jia, Zeng and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Glycyrrhizic acid: A promising carrier material for anticancer therapy.Biomed Pharmacother. 2017 Nov;95:670-678. doi: 10.1016/j.biopha.2017.08.123. Epub 2017 Sep 7. Biomed Pharmacother. 2017. PMID: 28886526 Review.
-
Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects.Front Pharmacol. 2018 Nov 6;9:1253. doi: 10.3389/fphar.2018.01253. eCollection 2018. Front Pharmacol. 2018. PMID: 30459615 Free PMC article. Review.
-
[Effect of 18alpha-glycyrrhizic acid and 18beta-glycyrrhizic acid on P-gp function and expression in Caco-2 cells].Zhongguo Zhong Yao Za Zhi. 2012 Jan;37(1):99-103. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 22741471 Chinese.
-
Preparation of paeoniflorin-glycyrrhizic acid complex transethosome gel and its preventive and therapeutic effects on melasma.Eur J Pharm Sci. 2024 Jan 1;192:106664. doi: 10.1016/j.ejps.2023.106664. Epub 2023 Dec 5. Eur J Pharm Sci. 2024. PMID: 38061662
-
[The absorption features of glycyrrhizic acid in composition of drug "phosphogliv"].Biomed Khim. 2012 Sep-Oct;58(5):564-72. doi: 10.18097/pbmc20125805564. Biomed Khim. 2012. PMID: 23289298 Russian.
Cited by
-
Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin.PLoS One. 2024 Aug 16;19(8):e0307038. doi: 10.1371/journal.pone.0307038. eCollection 2024. PLoS One. 2024. PMID: 39150932 Free PMC article.
-
Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis.Oncol Lett. 2025 Mar 4;29(4):207. doi: 10.3892/ol.2025.14954. eCollection 2025 Apr. Oncol Lett. 2025. PMID: 40070780 Free PMC article.
-
Traditional Chinese medicine and its active substances reduce vascular injury in diabetes via regulating autophagic activity.Front Pharmacol. 2024 Mar 4;15:1355246. doi: 10.3389/fphar.2024.1355246. eCollection 2024. Front Pharmacol. 2024. PMID: 38505420 Free PMC article. Review.
-
Integrated Metabolomic and Transcriptomic Analysis Reveals the Pharmacological Effects and Differential Mechanisms of Isoflavone Biosynthesis in Four Species of Glycyrrhiza.Int J Mol Sci. 2025 Mar 12;26(6):2539. doi: 10.3390/ijms26062539. Int J Mol Sci. 2025. PMID: 40141180 Free PMC article.
-
Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer.Front Oncol. 2025 May 20;15:1602585. doi: 10.3389/fonc.2025.1602585. eCollection 2025. Front Oncol. 2025. PMID: 40463872 Free PMC article.
References
-
- Afkhami-Poostchi A., Mashreghi M., Iranshahi M., Matin M. M. (2020). Use of a genetically engineered E. coli overexpressing ÿ-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model. Int. J. Pharm. 579, 119159. 10.1016/j.ijpharm.2020.119159 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources